Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the impact of nicotine reduction on US smoking rates by end of 2026?
Decrease by over 10% • 25%
Decrease by 5-10% • 25%
Decrease by less than 5% • 25%
No significant decrease • 25%
Public health studies or reports from the Centers for Disease Control and Prevention (CDC)
Biden Administration Proposes 95% Nicotine Reduction in Cigarettes to Prevent 16 Million Addictions by 2060
Jan 13, 2025, 03:00 PM
The Biden administration is poised to propose a rule that would limit the amount of nicotine in cigarettes, aiming to reduce smoking addiction. This eleventh-hour effort, which has been years in the making, is expected to require tobacco companies to slash nicotine levels by up to 95% in their products to make them less addictive. The proposal would not affect e-cigarettes or nicotine replacement products. The move is seen as a last-ditch attempt by the outgoing administration to address tobacco regulation, following the failure to ban menthol cigarettes. Public health advocates have expressed support for the policy, noting its potential to help millions quit smoking and prevent others from becoming addicted, with estimates suggesting it could result in 16 million fewer people becoming addicted by 2060 and 33.1 million by 2100. Over 400,000 people die each year in the US from diseases associated with cigarette use, and cigarette smoking is the leading cause of preventable disease and death, killing more than 480,000 annually. The rule has not been made public, so the specific language is unknown, but it is anticipated to have a significant impact on public health if implemented.
View original story
No significant change • 25%
Decrease by less than 5% • 25%
Decrease by 5-10% • 25%
Decrease by over 10% • 25%
Increase • 25%
Minor decrease • 25%
Significant decrease • 25%
No change • 25%
Significant reduction in smoking rates • 25%
Increase in smoking rates • 25%
No change in smoking rates • 25%
Moderate reduction in smoking rates • 25%
No significant change • 25%
Reduced by less than 1% • 25%
Reduced by 1-2% • 25%
Reduced by over 2% • 25%
Decrease by more than 10% • 25%
Decrease by 5-10% • 25%
Decrease by less than 5% • 25%
No significant change • 25%
Withdrawn by FDA • 25%
Blocked by legal challenges • 25%
Implemented with modifications • 25%
Implemented without changes • 25%
Increase • 25%
Data Unavailable • 25%
No Change • 25%
Decrease • 25%
Decrease by 1-5% • 25%
Decrease by more than 5% • 25%
No significant change • 25%
Increase • 25%
No • 50%
Yes • 50%
Evenly split • 25%
Majority oppose • 25%
Majority support • 25%
Unclear/Other • 25%
Increase • 25%
Unclear • 25%
No Change • 25%
Decrease • 25%
No • 50%
Yes • 50%
Non-compliance and legal action • 25%
Compliance without legal action • 25%
Non-compliance without legal action • 25%
Compliance with legal action • 25%